Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Safeguard Biosystems has developed a proprietary multiplexed PCR and microarray-based molecular diagnostic platform capable of rapidly identifying a broad range of bacterial and fungal pathogens directly from complex sample matrices such as milk or blood. Their DairyGuard assay is commercially available to the dairy industry to improve herd health and milk quality by enabling early detection of mastitis-causing organisms. The technology has also been validated as a Laboratory Developed Test for use with human blood samples.[1] Clinical results indicate high correlation with traditional culture methods but with much faster turnaround times.[1]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safeguard Biosystems.